Actavis Laboratories is recalling specific lots of Desmopressin Acetate Tablets, 0.1mg, in 100-count bottles. The issue is that some tablets have been incorrectly imprinted with the letter 'X' on one side instead of the correct identification. This recall affects 11,445 bottles distributed nationwide. Read more at govinfonow.com/recall/44147-actavis-laboratories-fl-inc-recalls-desmopressin-acetate-tablets-0-1mg.
“Actavis Recalls Desmopressin Tablets Due to Wrong ID Imprint.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44147-actavis-laboratories-fl-inc-recalls-desmopressin-acetate-tablets-0-1mg. Based on FDA recall #D-1285-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1285-2015%22&limit=1).
The FDA announced on June 23, 2015, that Actavis Laboratories FL, Inc. is recalling Desmopressin Acetate Tablets because some tablets are incorrectly imprinted with an X. The agency classified the Class III recall as voluntary.
The hazard involves tablets and capsules imprinted with the wrong identification. Specifically, some tablets are incorrectly imprinted with an X on one side.
Context
GovInfoNow's records show Actavis Laboratories FL, Inc. has five other recalls on record since April 24, 2014. Other recent recalls of similar products include Unichem Recalls Doxazosin 4mg Tablets Due to Wrong ID Imprint (Jan. 21, 2026), SpecGx Oxycodone/Acetaminophen Tablets Recall: Missing Imprint Risk (Dec. 16, 2025), and Amneal Recalls Primidone Tablets Due to Cross-Contamination Risk (June 3, 2026).
How to tell if you have this one
Check your bottle for NDC 0591-2464-01 and Lot # 982021M with an expiry date of December 2016. Look closely at the tablets inside; if any are imprinted with an 'X' on one side, they are part of this recall. The product was manufactured by Actavis Laboratories FL, Inc., in Fort Lauderdale, FL.
Brand
Actavis
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check your bottle details
Verify if your bottle has NDC 0591-2464-01 and Lot # 982021M with an expiry of DEC. 2016.
Inspect the tablets
Look at the tablets to see if any are imprinted with an 'X' on one side.
Contact your pharmacist or doctor
Since no specific remedy is stated in the record, consult your healthcare provider for instructions on what to do next.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “U.S. Nationwide including Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 18 months after the firm started it.
1Firm started the recall
2FDA classified it Class III
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1285-2015 (June 23, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1285-2015 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.